Mandy Powell

@NattaCop I share your vision. As a virgin to share purchasing what number is a few shares in your opinion?

$OCGN yet again. Another trial, this one for Stargardt disease, advances, meaning the data was good. Multiple drugs using one platform all advancing and nearing commercialization, zero serious safety concerns, and stellar efficacy entering massively underserved markets. The more I see these results, the more I feel like the guy begging people to buy Bitcoin back in 2013. It’s just so damn obvious to me that the Phase 3 results in Q1 are going to be stellar. When that happens, the company is going to be re-rated based on the market they’re entering, as well as the other products that will shortly follow using the same platform technology. There are going to be a lot of rich shareholders, and all you’ve got to do is buy a few shares to join them. But most won’t. Why? I honestly don’t know.

@kevingreenwales Please advise if your book Rags to Ricges is available in audio and whether you are intending to hold a similar seminar in Birmingham?

Amazing fraction problem solving!! #superstar

@GaryBarlow please please come to my friend's 50th birthday party. She has had such sad times recently #makelynnneswishcometrue

@nataliemorley23 hey